Neuronal Transplantation for Alzheimer’s Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for Implantation

Alzheimer’s disease (AD) is a devastating neurodegenerative disease with limited therapeutic options. Cellular transplantation of healthy exogenic neurons to replace and restore neuronal cell function has previously been explored in AD animal models, yet most of these transplantation methods have ut...

Full description

Bibliographic Details
Main Authors: Phoebe Strell, Sether T. Johnson, Chris Carchi, Walter C. Low
Format: Article
Language:English
Published: SAGE Publishing 2023-05-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/09636897231164712
_version_ 1797821634184216576
author Phoebe Strell
Sether T. Johnson
Chris Carchi
Walter C. Low
author_facet Phoebe Strell
Sether T. Johnson
Chris Carchi
Walter C. Low
author_sort Phoebe Strell
collection DOAJ
description Alzheimer’s disease (AD) is a devastating neurodegenerative disease with limited therapeutic options. Cellular transplantation of healthy exogenic neurons to replace and restore neuronal cell function has previously been explored in AD animal models, yet most of these transplantation methods have utilized primary cell cultures or donor grafts. Blastocyst complementation offers a novel approach to generate a renewable exogenic source of neurons. These exogenic neurons derived from stem cells would develop with the in vivo context of the inductive cues within a host, thus recapitulating the neuron-specific characteristics and physiology. AD affects many different cell types including hippocampal neurons and limbic projection neurons, cholinergic nucleus basis and medial septal neurons, noradrenergic locus coeruleus neurons, serotonergic raphe neurons, and limbic and cortical interneurons. Blastocyst complementation can be adapted to generate these specific neuronal cells afflicted by AD pathology, by ablating important cell type and brain region–specific developmental genes. This review discusses the current state of neuronal transplantation to replace specific neural cell types affected by AD, and the developmental biology to identify candidate genes for knockout in embryos for creating niches to generate exogenic neurons via blastocyst complementation.
first_indexed 2024-03-13T09:56:40Z
format Article
id doaj.art-7350eea284034b4b8e378cd6e33527ad
institution Directory Open Access Journal
issn 1555-3892
language English
last_indexed 2024-03-13T09:56:40Z
publishDate 2023-05-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-7350eea284034b4b8e378cd6e33527ad2023-05-23T20:33:19ZengSAGE PublishingCell Transplantation1555-38922023-05-013210.1177/09636897231164712Neuronal Transplantation for Alzheimer’s Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for ImplantationPhoebe Strell0Sether T. Johnson1Chris Carchi2Walter C. Low3Stem Cell Institute, University of Minnesota, Minneapolis, MN, USADepartment of Neurosurgery, University of Minnesota, Minneapolis, MN, USADepartment of Biomedical Engineering, University of Minnesota, Minneapolis, MN, USADepartment of Biomedical Engineering, University of Minnesota, Minneapolis, MN, USAAlzheimer’s disease (AD) is a devastating neurodegenerative disease with limited therapeutic options. Cellular transplantation of healthy exogenic neurons to replace and restore neuronal cell function has previously been explored in AD animal models, yet most of these transplantation methods have utilized primary cell cultures or donor grafts. Blastocyst complementation offers a novel approach to generate a renewable exogenic source of neurons. These exogenic neurons derived from stem cells would develop with the in vivo context of the inductive cues within a host, thus recapitulating the neuron-specific characteristics and physiology. AD affects many different cell types including hippocampal neurons and limbic projection neurons, cholinergic nucleus basis and medial septal neurons, noradrenergic locus coeruleus neurons, serotonergic raphe neurons, and limbic and cortical interneurons. Blastocyst complementation can be adapted to generate these specific neuronal cells afflicted by AD pathology, by ablating important cell type and brain region–specific developmental genes. This review discusses the current state of neuronal transplantation to replace specific neural cell types affected by AD, and the developmental biology to identify candidate genes for knockout in embryos for creating niches to generate exogenic neurons via blastocyst complementation.https://doi.org/10.1177/09636897231164712
spellingShingle Phoebe Strell
Sether T. Johnson
Chris Carchi
Walter C. Low
Neuronal Transplantation for Alzheimer’s Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for Implantation
Cell Transplantation
title Neuronal Transplantation for Alzheimer’s Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for Implantation
title_full Neuronal Transplantation for Alzheimer’s Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for Implantation
title_fullStr Neuronal Transplantation for Alzheimer’s Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for Implantation
title_full_unstemmed Neuronal Transplantation for Alzheimer’s Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for Implantation
title_short Neuronal Transplantation for Alzheimer’s Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for Implantation
title_sort neuronal transplantation for alzheimer s disease and prospects for generating exogenic neurons as a source of cells for implantation
url https://doi.org/10.1177/09636897231164712
work_keys_str_mv AT phoebestrell neuronaltransplantationforalzheimersdiseaseandprospectsforgeneratingexogenicneuronsasasourceofcellsforimplantation
AT sethertjohnson neuronaltransplantationforalzheimersdiseaseandprospectsforgeneratingexogenicneuronsasasourceofcellsforimplantation
AT chriscarchi neuronaltransplantationforalzheimersdiseaseandprospectsforgeneratingexogenicneuronsasasourceofcellsforimplantation
AT walterclow neuronaltransplantationforalzheimersdiseaseandprospectsforgeneratingexogenicneuronsasasourceofcellsforimplantation